Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma

Virotherapy using oncolytic vaccinia virus (VACV) strains is one promising new strategy for canine cancer therapy. In this study we describe the establishment of an in vivo model of canine soft tissue sarcoma (CSTS) using the new isolated cell line STSA-1 and the analysis of the virus-mediated oncol...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentschev, Ivaylo, Adelfinger, Marion, Josupeit, Rafael, Rudolph, Stephan, Ehrig, Klaas, Donat, Ulrike, Weibel, Stephanie, Chen, Nanhai G., Yu, Yong A., Zhang, Qian, Heisig, Martin, Thamm, Douglas, Stritzker, Jochen, MacNeill, Amy, Szalay, Aladar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352892/
https://www.ncbi.nlm.nih.gov/pubmed/22615950
http://dx.doi.org/10.1371/journal.pone.0037239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352892/
https://www.ncbi.nlm.nih.gov/pubmed/22615950
http://dx.doi.org/10.1371/journal.pone.0037239

Ejemplares similares